# Rickettsia Clearance Study

> **NCT05972772** · PHASE2,PHASE3 · RECRUITING · sponsor: **Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit** · enrollment: 72 (estimated)

## Conditions studied

- Infectious Disease
- Therapeutics

## Interventions

- **DRUG:** Doxycyclin
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT05972772
- **Lead sponsor:** Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2025-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2024-12-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05972772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05972772, "Rickettsia Clearance Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05972772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*